Search
Linkage Pharmaceutical: Operations Remain Stable; No Undisclosed Material Events
2025-07-21 /
Read about 0 minute
Author：小编
Linkage Pharmaceutical has announced that the deviation value of its stock's closing price increase over three consecutive trading days has reached 30%, triggering unusual market fluctuations. Following an internal review, the company confirms that its production and operational activities are proceeding normally. There have been no significant shifts in the market environment or industry policies, nor are there any material undisclosed matters involving the controlling shareholders or actual controllers.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
